Local Business Alert: HGS adopts ‘poison pill’

	Thursday, May 17, 2012 1:56:41 PM LOCAL BUSINESS ALERT HGS adopts 'poison pill' Rockville-based Human Genome Sciences enacted a stockholder rights plan Thursday in an effort to prevent drugmaker GlaxoSmithKline from purchasing the biotech company against the will of its board of directors. Read more at: http://www.washingtonpost.com/blogs/capital-business/post/hgs-adopts-poison-pill-in-response-to-glaxos-tender-offer/2012/05/17/gIQA74sPWU_blog.html Or visit Capital Business or the Local Business section on washingtonpost.com. SEND TO A FRIEND UNSUBSCRIBE E-MAIL CENTER GET HELP Washington Post Digital E-mail Customer Care 1150 15th Street NW Washington, D.C. 20071  ©2011 The Washington Post Privacy Policy